Beliefs, perceptions and behaviours of GPs towards generic medicines

Family Practice

Volumn 31, Issue 4, 2014, Pages

  Dunne, Suzanne S ^a   Shannon, Bill ^a   Cullen, Walter ^a   Dunne, Colum P ^a  

^a UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Generic drugs; GPs; Patient education; Perception; Professional education; Qualitative research

Indexed keywords

GENERIC DRUG;

ARTICLE; DRUG MANUFACTURE; DRUG QUALITY; GENERAL PRACTICE; HEALTH BELIEF; HUMAN; JOB EXPERIENCE; LABORATORY; PATIENT EDUCATION; PATIENT PREFERENCE; PATIENT RISK; PATIENT SAFETY; PERCEPTION; PHYSICIAN ATTITUDE; PRESCRIPTION; SEMI STRUCTURED INTERVIEW; CLINICAL PRACTICE; ECONOMICS; FEMALE; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; IRELAND; MALE; MIDDLE AGED; PSYCHOLOGY; QUALITATIVE RESEARCH;

ATTITUDE OF HEALTH PERSONNEL; DRUGS, GENERIC; FEMALE; GENERAL PRACTITIONERS; HUMANS; IRELAND; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUALITATIVE RESEARCH;

EID: 84904751847     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmu024     Document Type: Article

References (27)

1. Health (Pricing and Supply of Medical Goods) Act 2013. 2013. http://www.irishstatutebook.ie/2013/en/act/pub/0014/index.html (accessed 1 August 2013).
2. Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet. 2001; 357: 757-62.
3. Feely J, McGettigan P, O'Shea B, Chan R, McManus J. Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: prescribers' concerns. Ir Med J 1997; 90: 146-7.
4. Chua GN, Hassali MA, Shafie AA, Awaisu A. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy 2010; 95: 229-35.
5. Fraeyman J, De Winter J, De Loof H et al. [Opinions and attitudes of Flemish pharmacists and general practitioners towards INN prescribing. A survery in Antwerp and East Flanders]. J Pharm Belg 2013; 2: 18-31.
6. Jamshed SQ, Ibrahim MI, Hassali MA et al. Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: a questionnaire based study. South Med Rev 2012; 5: 22-30.
7. Kersnik J, Peklar J. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies. J Clin Pharm Ther 2006; 31: 577-83.
8. Lagarce L, Lusson-Brisset C, Bruhat C, Diquet B, Lainé-Cessac P. [How practitioners view generic drugs: an opinion study from general practitioners in Maine-et-Loire (France)]. Therapie 2005; 60: 67-74.
9. Simmenroth-Nayda A, Hummers-Pradier E, Ledig T et al. [Prescription of generic drugs in general practice. Results of a survey of general practitioners]. Med Klin (Munich) 2006; 101: 705-10.
10. Verger P, Gourheux JC, Villani P, Desquins B, Bouvenot G, Paraponaris A. [Willingness to prescribe by international non proprietary names: general practitioners attitudes in South East France in 2002]. Presse Med 2003; 32: 1022-5.
11. Murphy MB. Review of Indicative Drug Target Savings Scheme. Health Service Executive, 1997. Lenus, the Irish Health Repository. Lenus website. http://lenus.ie/hse/handle/10147/45486 (accessed 12 October 2012)
12. Moran M. Proposed Model for Reference Pricing and Generic Substitution. 2010. http://www.dohc.ie/publications/pdf/reference_pricing_ generic_substitution.pdf?direct=1 (accessed on 11 January 2011).
13. Dunne S, Shannon B, Dunne C, Cullen W. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacol Toxicol 2013; 14: 1.
14. Engward H. Understanding grounded theory. Nurs Stand 2013; 28: 37-41.
15. Hassali MA, Shafie AA, Awaisu A, Ibrahim MI, Chong Chee P, Jamshed S. Physicians' views on generic medicines: a narrative review. J Generic Med 2010; 7: 30-9.
16. Hassali MA, Kong DCM, Stewart K. Generic medicines: perceptions of general practitioners in Melbourne, Australia. J Generic Med 2006; 3: 214-25.
17. Mumoli N, Cei M, Luschi R, Carmignani G, Camaiti A. Allergic reaction to Croscarmellose sodium used as excipient of a generic drug. QJM. 2011; 104: 709-10.
18. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29: 385-96.
19. Chren MM, Landefeld CS. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 1994; 271: 684-9.
20. Fischer MA, Keough ME, Baril JL et al. Prescribers and pharmaceutical representatives: why are we still meeting? J Gen Intern Med 2009; 24: 795-801.
21. Boumil MM, Cutrell ES, Lowney KE, Berman HA. Pharmaceutical speakers' bureaus, academic freedom, and the management of promotional speaking at academic medical centers. J Law Med Ethics 2012; 40: 311-25.
22. Mackey TK, Liang BA. Physician payment disclosure under health care reform: will the sun shine? J Am Board Fam Med 2013; 26: 327-31.
23. Sah S, Fugh-Berman A. Physicians under the influence: social psychology and industry marketing strategies. J Law Med Ethics 2013; 41: 665-72.
24. Dunne S, Shannon B, Dunne C, Cullen W. Patient perceptions of generic medicines: a mixed-methods study. Patient 2014 January 3. [Epub ahead of print] doi:10.1007/s40271-013-0042-z.
25. Dunne S, Cummins NM, Hannigan A, Shannon B, Dunne C, Cullen W. A method for the design and development of medical or health care information websites to optimize search engine results page rankings on Google. J Med Internet Res 2013; 15: e183.
26. Innovating for Health: Patients, Physicians, the Pharmaceutical Industry and the NHS. London: Royal College of Physicans, 2009. http://www.rcplondon.ac.uk/sites/default/files/documents/innovatingfor- health.pdf (accessed 14 June 2013).
27. Gleeson M, Coyle P, Clarke Moloney M, Walsh SR, Grace PA. An audit of generic prescribing in a general surgical department. Ir J Med Sci 2013; 182: 403-8.